April 29th 2025
Preoperative breast MRI had no impact upon recurrence-free survival and overall survival for women with HER-2 positive, hormone receptor-negative breast cancer, according to a multivariable analysis of a new study involving nearly 1,100 women.
Can MRI Surveillance Have an Impact in Detecting Recurrence of Soft Tissue Sarcomas?
February 3rd 2023While acknowledging a moderate to high risk of bias in the retrospective studies reviewed for a recent meta-analysis, researchers found the current evidence supports the use of high-intensity magnetic resonance imaging (MRI) surveillance for detection of soft tissue sarcoma recurrence.
New Meta-Analysis Says MRI is Best Supplemental Imaging for Dense Breasts
January 31st 2023In a review of 22 studies and data from over 132,000 women with dense breasts and negative mammography exams, researchers found that magnetic resonance imaging (MRI) was superior to digital breast tomosynthesis, handheld ultrasound and automated whole breast ultrasound for the detection of breast cancer.
Abbreviated MRI and Early-Stage Hepatocellular Carcinoma: What a New Multicenter Study Reveals
January 25th 2023In a multicenter study involving nearly 300 patients, researchers found that abbreviated magnetic resonance imaging (MRI) had a sensitivity rate of 88.2 percent and a specificity rate of 89.1 percent for detecting early-stage hepatocellular carcinoma (HCC).
Meta-Analysis Reaffirms Benefits of O-RADS MRI for Diagnosing Indeterminate Adnexal Lesions
December 16th 2022In addition to summary sensitivity and specificity of 92 percent and 91 percent respectively for characterization of indeterminate adnexal lesions, the meta-analysis on pelvic magnetic resonance imaging (MRI) revealed higher summary malignancy rates for O-RADS MRI 4 and 5 lesions than predicted.
Could an Emerging AI Platform Supplant Traditional MRI for Assessing Prostate Cancer?
December 7th 2022The Food and Drug Administration has granted 510(k) clearance to iQuest (Avenda Health), an artificial intelligence (AI) platform that combines findings from magnetic resonance imaging (MRI), pathology reports and biopsy results to facilitate three-dimensional mapping of prostate cancer.
What BI-RADS Changes Are on the Way for Breast MRI Reporting?
December 2nd 2022In a recent lecture at the Radiological Society of North America (RSNA) conference, Wendy DeMartini, MD, discussed a variety of preliminary proposed changes to the Breast Imaging Reporting and Data System (BI-RADS) for breast magnetic resonance imaging (MRI) examinations.
Can MRI-Based Prostate Cancer Screening be a Viable Alternative to PSA Testing?
December 1st 2022In what may be the first study to assess the effectiveness of biparametric magnetic resonance imaging (MRI) for prostate cancer screening in a large cohort, researchers found that MRI screening had a significantly lower false positive rate and significantly higher positive predictive values (PPVs) than prostate-specific antigen (PSA)-based screening.
Enhancing MRI Efficiency and Quality: Can the New SIGNA Experience Have an Impact?
November 29th 2022Recently launched at the Radiological Society of North America (RSNA) conference, the SIGNA Experience reportedly features synergistic technologies and artificial intelligence (AI) advances that help improve the efficiency and quality of magnetic resonance imaging.
Current Insights on AI, Breast Cancer Screening and the FDA
November 8th 2022In a recently published article, researchers from Yale University discuss the pros and cons of current FDA regulations as they apply to the clearance and use of adjunctive artificial intelligence (AI) software with conventional breast cancer screening modalities such as mammography.
Radiotherapy for Prostate Cancer: Study Says MRI Guidance Significantly Reduces GU and GI Toxicities
October 28th 2022For patients undergoing stereotactic body radiotherapy (SBRT) for prostate cancer, the acute genitourinary (GU) toxicity rate associated with the procedure was 19 percent lower with magnetic resonance imaging (MRI) guidance in comparison to computed tomography (CT) guidance, according to new research presented recently at the American Society for Radiation Oncology (ASTRO) Annual Meeting.
Transvaginal Ultrasound or MRI: Which is More Effective in Evaluating Endometrial Cancer?
October 26th 2022In a new study looking at pre-operative assessment of low-grade endometrial cancer, researchers found that while magnetic resonance imaging (MRI) had 20 percent higher specificity than transvaginal ultrasound for deep myometrial invasion, there was no difference in sensitivity.
Study Suggests Shorter Duration of Radiation Therapy is Effective for High-Risk Prostate Cancer
October 24th 2022Five weeks of radiation therapy is just as effective as eight weeks of radiation treatment for men with high-risk prostate cancer, according to new research presented at the American Society for Radiation Oncology (ASTRO) Annual Meeting.
Philips Gets FDA Nod for MRI Head and Neck Radiotherapy Application
October 20th 2022For physicians performing radiotherapy treatment of soft tissue tumors in the head and neck, the MRCAT Head and Neck offers an artificial intelligence (AI) application that allows the use of magnetic resonance imaging (MRI) as the primary or sole imaging for procedure planning.
Recognizing the Role of Enterprise Imaging in Handling and Protecting Sensitive Patient Information
October 19th 2022While facilitating interdisciplinary colloaboration is a central objective with enterprise imaging platforms, this author says implementation of these platforms must ensure optimal patient privacy in sensitive cases involving abuse, assault and domestic violence.